Status: current, Defined. Date: 31-May 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4394571000168110 | Dilart HCT 160/12.5 mg (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet, 7 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4394581000168113 | Dilart HCT 160/12.5 mg tablet, 7, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dilart HCT 160/12.5 mg tablet, 7, bottle | Is a | Dilart HCT 160/12.5 mg tablet, 7 | true | Inferred relationship | Some | ||
| Dilart HCT 160/12.5 mg tablet, 7, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Dilart HCT 160/12.5 mg tablet, 7, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Dilart HCT 160/12.5 mg tablet, 7, bottle | has TP | Dilart HCT 160/12.5 mg | true | Inferred relationship | Some | ||
| Dilart HCT 160/12.5 mg tablet, 7, bottle | has TPUU | Dilart HCT 160/12.5 mg tablet | true | Inferred relationship | Some | 2106450250 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR